ACW actinogen medical limited

Approved anti-depressants typically report average MADRS...

  1. 513 Posts.
    lightbulb Created with Sketch. 20620
    Approved anti-depressants typically report average MADRS improvements of ~2 to 3 points over placebo groups
    https://hotcopper.com.au/data/attachments/6380/6380377-b8b06260892cb3d1c657ed4b03e710ea.jpg
    https://hotcopper.com.au/data/attachments/6380/6380372-8e7d24745ca246cf3704262a1c00f6fb.jpg

    The global antidepressants drugs market was valued at USD 17.02 billion in 2022
    and growing at a CAGR of 7.90% from 2023 to 2032. The market is expected to reach USD 36.41 billion by 2032. Antidepressants are professionally prescribed drugs that assist with treating depression.

    Xanamem = No Side Effects + Lower levels of depression + 3.6 EOT within FDA guidelines for a prescribed anti depressant (see above)

    An excellent presentation by the Actinogene CEO on market online.com.au with Sonia Madigan



    DYOR
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
2.1¢
Change
0.002(10.5%)
Mkt cap ! $66.72M
Open High Low Value Volume
1.9¢ 2.3¢ 1.9¢ $216.6K 10.28M

Buyers (Bids)

No. Vol. Price($)
2 524999 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.3¢ 94082 1
View Market Depth
Last trade - 16.10pm 24/06/2025 (20 minute delay) ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.